Advertisement

Study: Vaccines cut COVID-19 Delta variant death risk by 90%

By HealthDay News
1/3
Study: Vaccines cut COVID-19 Delta variant death risk by 90%
COVID-19 vaccines made by Pfizer, pictured, and AstraZeneca are 90% effective at preventing death from the Delta variant of the coronavirus, according to a new study out of Britain. File Photo by Debbie Hill/UPI | License Photo

The Pfizer and AstraZeneca coronavirus vaccines reduce the risk of death from the Delta variant by 90%, a new study in Britain finds.

The Delta variant is now the dominant form of the coronavirus in the United States, Britain and many other countries.

Advertisement

The study collected data from 5.4 million people in Scotland between April 1 and Sept. 27, 2021, is the first country-wide assessment of the effectiveness of vaccines in preventing death from the Delta variant.

The Pfizer vaccine was 90% effective and the AstraZeneca vaccine was 91% effective in people who were fully vaccinated but tested positive for the Delta variant, according to the findings published Wednesday as a letter in the New England Journal of Medicine.

RELATED Study: Pfizer vaccine 90% effective against severe COVID-19 for at least 6 months

AstraZeneca's vaccine is not available in the United States.

Deaths from COVID-19 were defined as anyone who died within 28 days of a positive PCR test, or who had COVID-19 listed as a cause of death on their death certificate.

The Moderna vaccine is also available in Scotland, but no deaths have been recorded in those who've received both doses, so it wasn't possible to estimate its effectiveness in preventing death, the researchers noted.

Advertisement
RELATED Experts: COVID-19 infection offers less protection than many think

They also said that the findings need to be confirmed by replicating their research in other countries/settings, and with longer follow-up after full vaccination.

"With the Delta variant now the dominant strain in many places worldwide and posing a higher risk of hospitalization than previous variants seen in [Britain], it is reassuring to see that vaccination offers such high protection from death very shortly after the second dose," study leader Aziz Sheikh, director of the University of Edinburgh's Usher Institute.

"If you still have not taken up your offer to be vaccinated, I would encourage you to do so based on the clear benefits it offers," Sheikh added in a university news release.

RELATED Pfizer says data show COVID-19 vaccine is safe, effective in children 5-11

"Our findings are encouraging in showing that the vaccine remains an effective measure in protecting both ourselves and others from death from the most dominant variant of COVID-19. It is very important to validate these early results in other settings and with a longer follow-up study," said Chris Robertson, a professor at the University of Strathclyde and Public Health Scotland.

More information

The U.S. Centers for Disease Control and Prevention has more on COVID-19 vaccines.

Copyright © 2021 HealthDay. All rights reserved.

Advertisement

Latest Headlines

Advertisement
Advertisement

Follow Us

Advertisement